Status:
ENROLLING_BY_INVITATION
Impact of Respiratory Allergy on Response to Initiation of Biotherapy in Severe Asthma in Adult Severe Asthmatic Patients Followed at Poitiers University Hospital on Biotherapy
Lead Sponsor:
Poitiers University Hospital
Conditions:
Severe Asthma
Biotherapy
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to take stock of the situation of adult patients with severe asthma on biotherapy, followed up at Poitiers University Hospital, and in particular to increase our knowledge of ...
Eligibility Criteria
Inclusion
- Severe asthma patient on biotherapy
- Age \> or = 18 years
- Follow-up at Poitiers University Hospital
Exclusion
- Absence of allergological assessment
- Patient's refusal to participate in study
Key Trial Info
Start Date :
March 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06916104
Start Date
March 1 2024
End Date
March 31 2025
Last Update
April 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Poitiers
Poitiers, France, 86000